Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II

A. Dietz*, G. Wichmann, T. Kuhnt, L. Pfreundner, R. Hagen, M. Scheich, O. Kölbl, M. G. Hautmann, J. Strutz, F. Schreiber, U. Bockmühl, V. Schilling, P. Feyer, M. De Wit, G. Maschmeyer, M. Jungehülsing, U. Schroeder, B. Wollenberg, C. Sittel, M. MünterT. Lenarz, J. P. Klussmann, O. Guntinas-Lichius, C. Rudack, H. T. Eich, T. Foerg, S. Preyer, M. Westhofen, H. J. Welkoborsky, D. Esser, D. Thurnher, S. Remmert, H. Sudhoff, M. Görner, J. Bünzel, V. Budach, S. Held, M. Knödler, F. Lordick, S. Wiegand, K. Vogel, A. Boehm, M. Flentje, U. Keilholz

*Corresponding author for this work
19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science